Bradykinin-12-lipoxygenase-VR1 signaling pathway for inflammatory hyperalgesia
AUTOR(ES)
Shin, Jieun
FONTE
The National Academy of Sciences
RESUMO
The capsaicin-sensitive vanilloid receptor (VR1) was recently shown to play an important role in inflammatory pain (hyperalgesia), but the underlying mechanism is unknown. We hypothesized that pain-producing inflammatory mediators activate capsaicin receptors by inducing the production of fatty acid agonists of VR1. This study demonstrates that bradykinin, acting at B2 bradykinin receptors, excites sensory nerve endings by activating capsaicin receptors via production of 12-lipoxygenase metabolites of arachidonic acid. This finding identifies a mechanism that might be targeted in the development of new therapeutic strategies for the treatment of inflammatory pain.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=126639Documentos Relacionados
- Attenuation of thermal nociception and hyperalgesia by VR1 blockers
- Protease-activated receptors and inflammatory hyperalgesia
- Tetrodotoxin-resistant Na+ currents and inflammatory hyperalgesia
- The MEK1–ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice
- Cloning of the cDNA for human 12-lipoxygenase.
